A detailed history of Cetera Investment Advisers transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 3,284 shares of ITCI stock, worth $279,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,284
Previous 2,964 10.8%
Holding current value
$279,107
Previous $203,000 18.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$67.99 - $80.84 $21,756 - $25,868
320 Added 10.8%
3,284 $240,000
Q2 2024

Aug 22, 2024

BUY
$64.76 - $79.84 $1,878 - $2,315
29 Added 0.99%
2,964 $203,000
Q1 2024

May 24, 2024

BUY
$64.37 - $75.65 $188,925 - $222,032
2,935 New
2,935 $203,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.02B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.